Endovascular treatment of infrarenal abdominal aortic aneurysm (AAA) offers a less invasive alternative to conventional open repair. Currently, only four devices are Food and Drug Administration (FDA)-approved for use in endovascular aneurysm repair (EVAR) of AAA in the United States. All four devices are associated with a high technical success rate and less morbidity than open surgical repair. Each device has its inherent design advantages and disadvantages that must be matched with patient and AAA characteristics. This review will discuss and compare the technology and procedural outcomes data of the current FDA-approved EVAR devices.